Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung
Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (107)
- Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. 2022-02-01 · Expand citations
- Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy. 2021-12-01 · Expand citations
- Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. 2021-11-08 · Expand citations
- Blinding and expectancy confounds in psychedelic randomized controlled trials. 2021-09-01 · Expand citations
- Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis 2021-06-12 · Expand citations
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
- Effectiveness of Psilocybin on Depression: A Qualitative Study 2021-04-27 · Expand citations
- Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
- A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain. 2021-01-15 · Expand citations
- Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity. 2020-07-15 · Expand citations
- A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. 2020-04-01 · Expand citations
- Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. 2020-02-01 · Expand citations
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. 2019-07-01 · Expand citations
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
- Effects of psilocybin therapy on personality structure. 2018-11-01 · Expand citations
- Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. 2018-11-01 · Expand citations
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
- Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder. 2018-01-01 · Expand citations
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. 2017-10-13 · Expand citations
- Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. 2017-10-01 · Expand citations
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
- Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. 2016-05-03 · Expand citations
- The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. 2016-01-01 · Expand citations
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. 2015-11-01 · Expand citations
- Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. 2015-10-15 · Expand citations
- Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. 2015-10-01 · Expand citations
- Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
- Homological scaffolds of brain functional networks. 2014-12-06 · Expand citations
- Enhanced repertoire of brain dynamical states during the psychedelic experience. 2014-11-01 · Expand citations
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
- Psilocybin--summary of knowledge and new perspectives. 2014-03-01 · Expand citations
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. 2014-01-01 · Expand citations
- Broadband cortical desynchronization underlies the human psychedelic state. 2013-09-18 · Expand citations
- Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. 2013-06-19 · Expand citations
- A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. 2013-06-01 · Expand citations
- Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. 2013-03-01 · Expand citations
- Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. 2012-12-01 · Expand citations
- Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. 2012-06-01 · Expand citations
- Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. 2012-03-01 · Expand citations
- Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. 2012-02-01 · Expand citations
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. 2011-11-01 · Expand citations
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. 2011-11-01 · Expand citations
- The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. 2011-03-01 · Expand citations
- Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. 2008-08-01 · Expand citations
- Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
- The pharmacology of psilocybin. 2002-10-01 · Expand citations
- 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride. 1999-05-01 · Expand citations
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. 1998-12-01 · Expand citations
- OpenAlex W173089895
- OpenAlex W176699989
- OpenAlex W1863427091
- OpenAlex W1974077854
- OpenAlex W1984615306
- OpenAlex W1986215651
- OpenAlex W1991771535
- OpenAlex W1995041454
- OpenAlex W2004762037
- OpenAlex W2009957469
- OpenAlex W2011700455
- OpenAlex W2023691686
- OpenAlex W2025623966
- OpenAlex W2029526731
- OpenAlex W2034911394
- OpenAlex W2053126345
- OpenAlex W2066650091
- OpenAlex W2087952727
- OpenAlex W2096375888
- OpenAlex W2100175023
- OpenAlex W2104016179
- OpenAlex W2113099805
- OpenAlex W2117693696
- OpenAlex W2121148760
- OpenAlex W2135176444
- OpenAlex W2136435696
- OpenAlex W2140018908
- OpenAlex W2147289447
- OpenAlex W2148523147
- OpenAlex W2148764920
- OpenAlex W2155757287
- OpenAlex W2328700233
- OpenAlex W2439685582
- OpenAlex W2515280853
- OpenAlex W2599766179
- OpenAlex W2603506674
- OpenAlex W2737505385
- OpenAlex W2757917284
- OpenAlex W2790959730
- OpenAlex W2887140173
- OpenAlex W2892664712
- OpenAlex W2894541203
- OpenAlex W2900604419
- OpenAlex W2903001666
- OpenAlex W2908855055
- OpenAlex W2912561908
- OpenAlex W3006905788
- OpenAlex W3007835064
- OpenAlex W3093454394
- OpenAlex W3201625402
- OpenAlex W4230668926
- OpenAlex W4231670147
- OpenAlex W4248028531
- OpenAlex W4319425390
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.